相关实验视频

Updated: Jul 23, 2025

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

火免疫疗法与间隔延长至12周S:FIRES研究

Brittanie Neaves¹, Karla Adams², Derek Smith²

¹Department of Allergy-Immunology, Keesler Medical Center, Biloxi, Mississippi.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

|July 16, 2023

概括

延长维持间隔 (EMI) 免疫疗法对于预防进口火 (IFA) 刺伤过敏反应是安全有效的. 这种方法减少了IFA过敏患者的注射和诊所访问.

科学领域:

过敏和免疫学过敏和免疫学
临床研究临床研究
毒理学毒理学毒理学

背景情况:

没有先前的研究评估了12周的延长维持间隔 (EMI) 免疫疗法 (IT) 对进口火 (IFA) 刺伤过敏反应的预防.
现有的研究缺乏关于IFA IT中长时间间隔的疗效的数据.

研究的目的:

评估12周维护间隔的安全性和有效性,用于接受IFA IT的患者.
为了确定延长间隔是否是IFA过敏管理的可行选择.

主要方法:

患有IFA过敏症的成年人接受了IT,经过3个月的传统IT后,每隔6,8和12周的维护间隔接受IT.
通过IFA年度刺客挑战来评估有效性.
在延长间隔注射和野外刺痛期间,监测系统反应的安全性.

主要成果:

25名患者启动了EMI;最初的反应范围从轻度到严重.
没有患者对延长间隔注射,集群补充,野外刺伤或刺伤挑战有系统反应.
治疗队列证明了12周EMI的安全性和有效性.

结论:

12周的EMI是对IFA过敏成年人的一种安全有效的治疗方法,这些成年人已经证明了传统IT的有效性.
电子注射提供了好处,包括注射次数减少,诊所访问减少,治疗时间缩短.
这项研究支持EMI作为IFA长期IT管理的实际选择.

更多相关视频

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.